Position in NTRA
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$35,288
+$27,289 QoQ
Shares Held
130
+225.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#711
of 844 holders
Holding Since
Mar 2024
9 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NTRA Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026Rakuten Securities, Inc. holds $104,029 across 10 Diagnostics & Research names. NTRA ranks #1 (33.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | NTRA |
Natera, Inc.
This page
|
130 | $35,288 | |
| 2 | ILMN |
Illumina, Inc.
|
185 | $32,528 | |
| 3 | GH |
Guardant Health, Inc.
|
101 | $15,153 | |
| 4 | IDXX |
Idexx Laboratories Inc /De
|
21 | $11,055 | |
| 5 | DHR |
Danaher Corp /De/
|
18 | $3,428 | |
| 6 | TMO |
Thermo Fisher Scientific Inc.
|
6 | $3,008 | |
| 7 | LH |
Labcorp Holdings Inc.
|
6 | $1,680 | |
| 8 | IQV |
Iqvia Holdings Inc.
|
5 | $966 |
All Filings in NTRA
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $35,288 | 130 | Shares | Defined | 2026-08-12 | |
| 2026-03-31 | $7,999 | 40 | Shares | Defined | 2026-05-01 | |
| 2025-09-30 | $1,448 | 9 | Shares | Defined | 2025-10-28 | |
| 2025-06-30 | $17,569 | 104 | Shares | Defined | 2025-08-15 | |
| 2025-03-31 | $31,110 | 220 | Shares | Defined | 2025-04-18 | |
| 2024-12-31 | $15,988 | 101 | Shares | Defined | 2025-02-10 | |
| 2024-09-30 | $20,565 | 162 | Shares | Defined | 2024-11-05 | |
| 2024-06-30 | $11,045 | 102 | Shares | Defined | 2024-07-31 | |
| 2024-03-31 | $1,188 | 13 | Shares | Defined | 2024-05-01 | |
| No filing history on record for this holder in this stock. | ||||||